This article provides a systematic comparison of Network-Based Inference (NBI) and Similarity Inference methods for predicting drug-target interactions (DTIs), a critical task in drug discovery and repurposing.
Hit identification is a critical, foundational stage in drug discovery, and the choice of screening library profoundly impacts the campaign's success.
This article provides a comprehensive guide for researchers and drug development professionals on integrating chemogenomics with phenotypic screening to validate hits and identify mechanisms of action.
This article provides a rigorous comparison of matrix factorization and deep learning methodologies for predicting drug-target interactions (DTIs), a critical task in accelerating drug discovery and repositioning.
This article provides a comprehensive overview of chemogenomic profiling as a powerful system-based approach for validating the mechanism of action (MoA) of small molecules in drug discovery.
This article provides a comprehensive framework for researchers and drug development professionals to benchmark chemogenomic libraries against diverse bioactive compound sets.
This article provides a comprehensive comparative analysis of network-based inference (NBI) methods for predicting drug-target interactions (DTIs) and drug repositioning.
This article provides a comprehensive guide for researchers and drug development professionals on the critical process of validating chemogenomic predictions using robust in vitro assays.
Accurate prediction of Drug-Target Interactions (DTIs) is a critical, yet challenging, step in accelerating drug discovery and repurposing.
This article provides a comprehensive framework for optimizing Absorption, Distribution, Metabolism, and Excretion (ADME) properties within chemogenomic libraries, which are essential tools for modern phenotypic and target-based drug discovery.